← SynDRA
3-(1H-Indazol-5-yl)-N-propylimidazo(1,2-b)pyridazin-6-amine
SynDRA canonical compound SYN2233620 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GSG2 |
|---|
| Mechanism of action | serine/threonine kinase inhibitor |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- AURKB
- CSNK1E
- GSK3A
- GSK3B
- HASPIN
- JAK3
- PIM1
- PGK1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CCNA2
- CCNB1
- SYK
- PNMT
- NTMT1
- NTM1A
- NSD2
- NNMT
- KSYK
- HNMT
- GNMT
- GAMT
- COMT
- CDK9
- CDK5R1
- CDK5
- CDK2
- CDK1
- CCNT1
- TP53
Cross-references
Synonyms
- 3-(1H-indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine
- RefChem:273320
- DTXCID80693373
- CHR-6494
- 3-(1H-Indazol-5-yl)-N-propylimidazo-[1,2-b]pyridazin-6-amine
- MFCD22666352
- orb1707450
- SCHEMBL25009244
- GLXC-15433
- BDBM50587785
- CHR-6494?
- AKOS025149446
- CS-0994
- EBC-606458
- NCGC00370724-05
- NCGC00370724-06
- DA-25622
- HY-15217
- F84874
- T14959
- BRD-K76259716-001-01-9
- BRD-K76259716-019-01-1
- 3-(1H-indazol-5-yl)-N-propyl-imidazo[1,2-b]pyridazin-6-amine
Look up 3-(1H-Indazol-5-yl)-N-propylimidazo(1,2-b)pyridazin-6-amine in the interactive SynDRA portal →